World travel with type 1 diabetes using continuous subcutaneous insulin infusion
- 17 December 2019
- journal article
- review article
- Published by ABCD Diabetes Care, Ltd. in British Journal of Diabetes
- Vol. 19 (2), 141-146
- https://doi.org/10.15277/bjd.2019.224
Abstract
Living with type 1 diabetes and using continuous subcutaneous insulin infusion (CSII), the authors travelled together for four months through 11 countries. Travelling with type 1 diabetes presents various added challenges. Personal experience of the challenges faced by the authors in relation to their diabetes are discussed along with the ways they were able to overcome these challenges. A review of general aspects one may encounter when travelling with type 1 diabetes and CSII follows. This provides an insightful overview for individuals living with type 1 diabetes intending to travel as well as healthcare professionals involved in providing care to those with type 1 diabetes intending to travel.Keywords
This publication has 8 references indexed in Scilit:
- Management of Diabetes During Air Travel: A Systematic Literature Review of Current Recommendations and their Supporting EvidenceEndocrine Practice, 2018
- Tasting in the air: A reviewInternational Journal of Gastronomy and Food Science, 2017
- Diabetes, trekking and high altitude: recognizing and preparing for the risksDiabetic Medicine, 2015
- Physical Activity at Altitude: Challenges for People With DiabetesDiabetes Care, 2014
- Changes in Altitude Cause Unintended Insulin Delivery From Insulin PumpsDiabetes Care, 2011
- Increased Insulin Requirements During Exercise at Very High Altitude in Type 1 DiabetesDiabetes Care, 2011
- Cardiovascular Risk Factors and Venous ThromboembolismJournal of the American College of Cardiology, 2008
- Air travel and thrombosisBritish Journal of Haematology, 2005